BRPI0508865A - dispositivo de liberação de medicamento visìvel por raio x - Google Patents

dispositivo de liberação de medicamento visìvel por raio x

Info

Publication number
BRPI0508865A
BRPI0508865A BRPI0508865-8A BRPI0508865A BRPI0508865A BR PI0508865 A BRPI0508865 A BR PI0508865A BR PI0508865 A BRPI0508865 A BR PI0508865A BR PI0508865 A BRPI0508865 A BR PI0508865A
Authority
BR
Brazil
Prior art keywords
drug delivery
delivery device
ray visible
visible drug
ray
Prior art date
Application number
BRPI0508865-8A
Other languages
English (en)
Inventor
Harm Veenstra
Wouter De Graaff
Original Assignee
Organon Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34928916&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0508865(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Organon Nv filed Critical Organon Nv
Publication of BRPI0508865A publication Critical patent/BRPI0508865A/pt
Publication of BRPI0508865B1 publication Critical patent/BRPI0508865B1/pt
Publication of BRPI0508865B8 publication Critical patent/BRPI0508865B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0404—X-ray contrast preparations containing barium sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0409—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is not a halogenated organic compound
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Materials For Medical Uses (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Pyrrole Compounds (AREA)
  • Indole Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

"DISPOSITIVO DE LIBERAçãO DE MEDICAMENTO VISìVEL POR RAIO X" A invenção objeto fornece um dispositivo de liberação de medicamento visível por raio X para a administração subdérmica de uma terapia contraceptiva ou de reposição hormonal.
BRPI0508865A 2004-03-19 2005-03-14 dispositivo de liberação de medicamento visível por raio x BRPI0508865B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP04101151.1 2004-03-19
EP04101151 2004-03-19
PCT/EP2005/051150 WO2005089814A1 (en) 2004-03-19 2005-03-14 X-ray visible drug delivery device

Publications (3)

Publication Number Publication Date
BRPI0508865A true BRPI0508865A (pt) 2007-09-04
BRPI0508865B1 BRPI0508865B1 (pt) 2018-07-10
BRPI0508865B8 BRPI0508865B8 (pt) 2021-05-25

Family

ID=34928916

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0508865A BRPI0508865B8 (pt) 2004-03-19 2005-03-14 dispositivo de liberação de medicamento visível por raio x

Country Status (33)

Country Link
US (1) US8722037B2 (pt)
EP (1) EP1729819B1 (pt)
JP (1) JP5055501B2 (pt)
KR (1) KR101086619B1 (pt)
CN (1) CN1953770B (pt)
AR (1) AR048106A1 (pt)
AT (1) ATE399569T1 (pt)
AU (1) AU2005224054B2 (pt)
BR (1) BRPI0508865B8 (pt)
CA (1) CA2559250C (pt)
CY (1) CY1108362T1 (pt)
DE (1) DE602005007873D1 (pt)
DK (1) DK1729819T3 (pt)
EC (1) ECSP066865A (pt)
EG (1) EG24359A (pt)
ES (1) ES2308460T3 (pt)
HK (1) HK1096316A1 (pt)
HR (1) HRP20080414T3 (pt)
IL (1) IL177970A (pt)
LV (1) LV13521B (pt)
MX (1) MXPA06010714A (pt)
MY (1) MY142649A (pt)
NO (1) NO338191B1 (pt)
NZ (1) NZ549877A (pt)
PE (1) PE20060022A1 (pt)
PL (1) PL1729819T3 (pt)
PT (1) PT1729819E (pt)
RU (1) RU2384347C2 (pt)
SI (1) SI1729819T1 (pt)
TW (1) TWI434676B (pt)
UA (1) UA86404C2 (pt)
WO (1) WO2005089814A1 (pt)
ZA (1) ZA200607602B (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006500115A (ja) 2000-11-16 2006-01-05 マイクロスフエリツクス・エル・エル・シー 密封小線源治療用の可撓性および／または弾性シードまたはストランド
TWI434676B (zh) 2004-03-19 2014-04-21 Merck Sharp & Dohme 可用ｘ射線看出之藥物遞送裝置
CN101437571B (zh) 2005-10-13 2013-01-02 斯恩蒂斯有限公司 载药包装物
TWI590843B (zh) 2011-12-28 2017-07-11 信迪思有限公司 膜及其製造方法
EP3010560B1 (en) 2013-06-21 2020-01-01 DePuy Synthes Products, Inc. Films and methods of manufacture
CA3023364A1 (en) * 2016-05-12 2017-11-16 Merck Sharp & Dohme Corp. Drug delivery system for the delivery of antiviral agents
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
US10406336B2 (en) 2016-08-03 2019-09-10 Neil S. Davey Adjustable rate drug delivery implantable device
US9980850B2 (en) 2016-09-29 2018-05-29 Gesea Biosciences, Inc. Bioerodible contraceptive implant and methods of use thereof
US20190008792A1 (en) * 2017-07-08 2019-01-10 Hera Health Solutions Inc. Bioerodible drug delivery implants
CN111989068A (zh) 2018-05-24 2020-11-24 塞拉尼斯伊娃高性能聚合物公司 用于持续释放大分子药物化合物的可植入器件
MX2020012458A (es) 2018-05-24 2021-04-28 Celanese Eva Performance Polymers Llc Dispositivo implantable para liberacion sostenida de un compuesto de farmaco macromolecular.

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE8123912U1 (de) 1981-08-17 1982-01-14 B. Braun Melsungen Ag, 3508 Melsungen Sonde aus kunststoff
LU85320A1 (fr) 1984-04-17 1985-11-27 Oreal Composition cosmetique contenant de l'aloesine a titre d'agent de protection contre la lumiere solaire et son utilisation pour la protection de la peau et des cheveux
GB8430703D0 (en) 1984-12-05 1985-01-16 Lrc Products Drug release devices
US4866132A (en) * 1986-04-17 1989-09-12 The Research Foundation Of State University Of New York Novel radiopaque barium polymer complexes, compositions of matter and articles prepared therefrom
DE19975054I2 (de) * 1987-08-08 2000-04-13 Akzo Nobel Nv Kontrazeptives Implantat
DE3867759D1 (de) 1987-08-18 1992-02-27 Akzo Nv Injektionsvorrichtung fuer ein implantat.
JPH01178540A (ja) 1987-12-29 1989-07-14 Mitsubishi Cable Ind Ltd 医療用チューブ成形用組成物
US5141522A (en) * 1990-02-06 1992-08-25 American Cyanamid Company Composite material having absorbable and non-absorbable components for use with mammalian tissue
DE4320754A1 (de) 1993-06-23 1995-01-05 Hoechst Ag Vorrichtung zum Applizieren von Implantaten
GB9401577D0 (en) 1994-01-27 1994-03-23 Sheffield Orthodontic Lab Limi Polymer material suitable for the production of medical artifacts
US6162236A (en) * 1994-07-11 2000-12-19 Terumo Kabushiki Kaisha Trocar needle and expandable trocar tube
AU5025096A (en) 1995-02-27 1996-09-18 Instent Inc. Hollow stent
US6171326B1 (en) 1998-08-27 2001-01-09 Micrus Corporation Three dimensional, low friction vasoocclusive coil, and method of manufacture
US6174329B1 (en) 1996-08-22 2001-01-16 Advanced Cardiovascular Systems, Inc. Protective coating for a stent with intermediate radiopaque coating
AU738006B2 (en) 1997-06-20 2001-09-06 Akzo Nobel N.V. Preloaded implantation device
US6174330B1 (en) * 1997-08-01 2001-01-16 Schneider (Usa) Inc Bioabsorbable marker having radiopaque constituents
WO1999024490A1 (en) 1997-11-07 1999-05-20 Rutgers, The State University Strictly alternating poly(alkylene oxide ether) copolymers
US6159165A (en) 1997-12-05 2000-12-12 Micrus Corporation Three dimensional spherical micro-coils manufactured from radiopaque nickel-titanium microstrand
EP0938894A1 (en) 1998-02-16 1999-09-01 Biomat B.V. Implantable radiopaque device and use thereof
US6171297B1 (en) * 1998-06-30 2001-01-09 Schneider (Usa) Inc Radiopaque catheter tip
DE29908415U1 (de) 1999-05-18 1999-07-22 Carl, Wolfgang, Dr.med.dent., 66386 St Ingbert Mittel zur Behandlung lokaler parodontaler Infektionen
DE19946606B4 (de) * 1999-09-29 2013-07-04 Robert Bosch Gmbh Vorrichtung zum Bilden eines Kraftstoff-Luftgemischs für einen Verbrennungsmotor während einer Warmlaufphase
EP1227845A2 (de) 1999-11-09 2002-08-07 Forschungszentrum Karlsruhe GmbH Seltene erden enthaltene mischung und deren verwendung
FR2803304B1 (fr) * 1999-12-29 2006-03-24 Ceca Sa Inhibiteurs de depots inorganiques, notamment dans les puits petroliers
US6355058B1 (en) 1999-12-30 2002-03-12 Advanced Cardiovascular Systems, Inc. Stent with radiopaque coating consisting of particles in a binder
DE10004832A1 (de) * 2000-01-31 2001-08-16 Ethicon Gmbh Flächiges Implantat mit röntgensichtbaren Elementen
SE0000363L (sv) 2000-02-04 2001-08-05 Zoucas Kirurgkonsult Ab Belagd medicinsk anordning
FI20000572A (fi) 2000-03-13 2001-09-14 Leiras Oy Implantaattien asettamiseen tarkoitettu laite
DE10014518A1 (de) * 2000-03-23 2001-10-04 Aventis Pharma Gmbh Vorrichtung zum Applizieren von Implantaten
WO2002041929A1 (de) 2000-11-21 2002-05-30 Schering Ag Röhrenförmige gefässimplantate (stents) sowie verfahren zur deren herstellung
US20020138136A1 (en) 2001-03-23 2002-09-26 Scimed Life Systems, Inc. Medical device having radio-opacification and barrier layers
JP4901021B2 (ja) 2001-06-06 2012-03-21 川澄化学工業株式会社 カテーテルチューブ
US6911219B2 (en) 2001-09-27 2005-06-28 Surgica Corporation Partially acetalized polyvinyl alcohol embolization particles, compositions containing those particles and methods of making and using them
AUPR951501A0 (en) 2001-12-14 2002-01-24 Smart Drug Systems Inc Modified sustained release pharmaceutical system
US6887270B2 (en) * 2002-02-08 2005-05-03 Boston Scientific Scimed, Inc. Implantable or insertable medical device resistant to microbial growth and biofilm formation
US8133501B2 (en) 2002-02-08 2012-03-13 Boston Scientific Scimed, Inc. Implantable or insertable medical devices for controlled drug delivery
US7462366B2 (en) 2002-03-29 2008-12-09 Boston Scientific Scimed, Inc. Drug delivery particle
US7214206B2 (en) 2003-04-03 2007-05-08 Valera Pharmaceuticals, Inc. Implanting device and method of using same
DE10355087A1 (de) * 2003-11-24 2005-06-09 Basf Ag Verfahren zur elektrochemischen Herstellung eines kristallinen porösen metallorganischen Gerüstmaterials
TWI434676B (zh) 2004-03-19 2014-04-21 Merck Sharp & Dohme 可用ｘ射線看出之藥物遞送裝置
AU2006207447B2 (en) * 2005-01-24 2012-07-19 Merck Sharp & Dohme B.V. Applicator for inserting an implant
MX2007008880A (es) 2005-01-24 2007-08-14 Organon Nv Aplicador para insertar un implante.
USD551759S1 (en) * 2005-06-13 2007-09-25 N. V. Organon Applicator for inserting an implant
EP1984063B1 (en) * 2006-01-19 2019-08-14 Merck Sharp & Dohme B.V. Kit for and method of assembling an applicator for inserting an implant

Also Published As

Publication number Publication date
HK1096316A1 (en) 2007-06-01
HRP20080414T3 (en) 2008-09-30
CN1953770B (zh) 2011-10-12
TWI434676B (zh) 2014-04-21
RU2006136913A (ru) 2008-04-27
CA2559250C (en) 2012-07-17
DE602005007873D1 (de) 2008-08-14
KR20070027530A (ko) 2007-03-09
SI1729819T1 (sl) 2008-12-31
PL1729819T3 (pl) 2008-11-28
ATE399569T1 (de) 2008-07-15
ECSP066865A (es) 2006-11-24
PE20060022A1 (es) 2006-02-11
LV13521B (en) 2007-07-20
CY1108362T1 (el) 2014-02-12
MXPA06010714A (es) 2007-03-08
AR048106A1 (es) 2006-03-29
DK1729819T3 (da) 2008-10-20
PT1729819E (pt) 2008-10-02
MY142649A (en) 2010-12-15
EP1729819A1 (en) 2006-12-13
CA2559250A1 (en) 2005-09-29
AU2005224054B2 (en) 2009-12-17
BRPI0508865B1 (pt) 2018-07-10
NO338191B1 (no) 2016-08-01
US8722037B2 (en) 2014-05-13
JP5055501B2 (ja) 2012-10-24
KR101086619B1 (ko) 2011-11-23
US20080112892A1 (en) 2008-05-15
ES2308460T3 (es) 2008-12-01
TW200534838A (en) 2005-11-01
EG24359A (en) 2009-03-04
AU2005224054A1 (en) 2005-09-29
EP1729819B1 (en) 2008-07-02
IL177970A (en) 2010-12-30
CN1953770A (zh) 2007-04-25
JP2007529469A (ja) 2007-10-25
NO20064716L (no) 2006-11-28
RU2384347C2 (ru) 2010-03-20
ZA200607602B (en) 2008-05-28
WO2005089814A1 (en) 2005-09-29
NZ549877A (en) 2009-07-31
UA86404C2 (ru) 2009-04-27
BRPI0508865B8 (pt) 2021-05-25
IL177970A0 (en) 2006-12-31

Similar Documents

Publication Publication Date Title
BRPI0508865A (pt) dispositivo de liberação de medicamento visìvel por raio x
BRPI0406486A (pt) Dispositivo de administração para medicamento fluido
MA28914B1 (fr) Mecanisme d'affichage de la dose pour dispositif de distribution de medicaments
MY167123A (en) Conveniently implantable sustained release drug compositions
DE602005024982D1 (de) Medizinprodukte mit selbstformender ratenkontrollierender barriere für die arzneiabgabe
AU2003295614A8 (en) Delivery of pharmaceutical agents via the human insulin receptor
HK1083688A1 (en) Drug delivery system for administering an adjustable preset dose
BRPI0519171A2 (pt) dispositivo de administraÇço de medicamento oftÁlmico
EA201170297A1 (ru) Имплантируемое устройство для доставки лекарственных средств и способ лечения мужской мочеполовой системы и окружающих тканей
BRPI0513300A (pt) forma farmacêutica oral, protegida frente ao abuso, contendo (1r, 2r)-3-(3-dimetilamino-1-etil-2-propil)-fenol
EP1558220A4 (en) ORAL COMPOSITIONS FOR THE TREATMENT OF DISEASES
EA201100544A1 (ru) Применение комбинации опиоидного агониста и конъюгата полимер-опиоидный антагонист для изготовления лекарственного средства для лечения и предупреждения боли
BRPI0400214A (pt) Composições e aplicações farmacêuticas para a obtenção confiável de nìveis aceitáveis de testosterona no soro
NO20033446L (no) Medikament for behandling av osteonekrose og for behandling av pasienter som har riskio for a utvikle osteonekrose
MX2010006388A (es) Bis-piridilpiridonas como antagonistas del receptor 1 de la hormona concentradora de melanina.
BR112013018739A2 (pt) sistema de distribuição de medicamento ocular
AR048318A1 (es) Formulaciones de matriz orales que comprenden licarbazepina
AU2003243439A8 (en) Medical device for intra-lumenal delivery of pharmaceutical agents
GB0306977D0 (en) Device
TW200744610A (en) New regimens for controlled drug delivery devices for contraception
BRPI0513186A (pt) composição medicinal para a administração oral
MA53227A (fr) Mécanisme d'activation pour dispositif d'administration de médicament
WO2005011589A3 (en) Drug delivery methods and devices
MY169854A (en) Conveniently implantable sustained release drug compositions

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B25A Requested transfer of rights approved

Owner name: MSD OSS B.V. (NL)

B25A Requested transfer of rights approved

Owner name: ORGANON BIOSCIENCES NEDERLAND B.V. (NL)

B25A Requested transfer of rights approved

Owner name: MERCK SHARP AND DOHME B.V. (NL)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]
B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 14/03/2005 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF